14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of EVAX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Thursday for Evaxion Biotech A/S
(Updated on May 02, 2024)

Hold candidate since May 01, 2024 Loss -0.51% PDF

The Evaxion Biotech A/S stock price fell by -0.512% on the last day (Thursday, 2nd May 2024) from $3.91 to $3.89. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 4.11% from a day low at $3.89 to a day high of $4.05. The price has fallen in 7 of the last 10 days and is down by -7.82% for this period. Volume has increased on the last day by 4 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 8 thousand shares were bought and sold for approximately $29.19 thousand.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 4.19% during the next 3 months and, with a 90% probability hold a price between $3.14 and $4.52 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

EVAX Signals & Forecast

The Evaxion Biotech A/S stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $4.10. On a fall, the stock will find some support from the long-term average at approximately $3.70. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, April 19, 2024, and so far it has fallen -9.74%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Evaxion Biotech A/S gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Evaxion Biotech A/S stock

Evaxion Biotech A/S finds support from accumulated volume at $3.88 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.160 between high and low, or 4.11%. For the last week, the stock has had daily average volatility of 4.91%.

Our recommended stop-loss: $3.69 (-5.20%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 9 days ago.)

Trading Expectations (EVAX) For The Upcoming Trading Day Of Friday 3rd

For the upcoming trading day on Friday, 3rd we expect Evaxion Biotech A/S to open at $3.94, and during the day (based on 14 day Average True Range), to move between $3.64 and $4.14, which gives a possible trading interval of +/-$0.254 (+/-6.54%) up or down from last closing price. If Evaxion Biotech A/S takes out the full calculated possible swing range there will be an estimated 13.08% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.88 (0.26%) than the resistance at $3.99 (2.57%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Evaxion Biotech A/S stock A Buy?

Evaxion Biotech A/S holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.617 Hold/Accumulate Unchanged

Predicted Opening Price for Evaxion Biotech A/S of Friday, May 3, 2024

Fair opening price May 3, 2024 Current price
$3.94 ( 1.37%) $3.89

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for EVAX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.10 5.48 %
R2 4.04 3.91 %
R1 4.00 2.94 %
Current price: 3.89
Support S1 3.88 -0.200 %
S2 3.84 -1.17 %
S3 3.78 -2.74 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 4.50 15.68 %
R2 4.21 8.23 %
R1 3.99 2.57 %
Current price 3.89
Support S1 3.88 -0.257%
S2 3.60 -7.46%
S3 3.02 -22.37%

FAQ

What is the symbol for Evaxion Biotech A/S Stock and on which exchange is it traded?
The symbol for Evaxion Biotech A/S is EVAX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Evaxion Biotech A/S Stock?
Evaxion Biotech A/S holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Evaxion Biotech A/S Stock?
Evaxion Biotech A/S Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Evaxion Biotech A/S Stock.

What's the current price of Evaxion Biotech A/S Stock?
As of the end of day on the May 02, 2024, the price of an Evaxion Biotech A/S (EVAX) share was $3.89.

What is the 52-week high and low for Evaxion Biotech A/S Stock?
The 52-week high for Evaxion Biotech A/S Stock is $13.55 and the 52-week low is $0.470.

What is the market capitalization of Evaxion Biotech A/S Stock?
As of the May 02, 2024, the market capitalization of Evaxion Biotech A/S is 20.287M.

When is the next earnings date for Evaxion Biotech A/S?
The upcoming earnings date for Evaxion Biotech A/S is May 29, 2024.
Click to get the best stock tips daily for free!

About Evaxion Biotech A/S

Evaxion Biotech A/S Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various... EVAX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT